Antagonism of intestinal bacteria isolated from human infants against Escherichia coli O157:H7 infection in gnotobiotic mice

Microbial Ecology in Health and Disease

Volumn 17, Issue 1, 2005, Pages 9-14

  Momose, Yoshika ^a   Hirayama, Kazuhiro ^a   Itoh, Kikuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bifidobacterium; Enterobacteriaceae; Escherichia coli O157:H7; Gnotobiotic mice; Infant intestinal flora

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIFIDOBACTERIUM; CLOSTRIDIUM; CONTROLLED STUDY; ENTERITIS; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI O157; FECES ANALYSIS; FECES CULTURE; FEMALE; GNOTOBIOTICS; HUMAN; INFANT; INTESTINE; INTESTINE FLORA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

BIFIDOBACTERIUM; CLOSTRIDIUM; ENTEROBACTERIACEAE; ESCHERICHIA COLI; MICROBIOTA;

EID: 18844396452     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600510027308     Document Type: Article

References (27)

1. Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr. 1994;125:511-8.
2. Shiomi M, Togawa M, Fujita K, Murata R. Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7. Pediatr Int. 1999;41:228-32.
3. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol. 1999;52:357-62.
4. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930-6.
5. Grif K, Dierich MP, Karch H, Allerberger F. Strain-specific differences in the amount of shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1998;17:761-6.
6. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DWK. Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis. 2000;181:664-70.
7. Donskey CJ, Hume ME, Callaway TR, Das SM, Hoyen CK, Rice LB. Inhibition of vancomycin-resistant enterococci by an in vitro continuous-flow competitive exclusion culture containing human stool flora. J Infect Dis. 2001;184:1624-7.
8. Freter R. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs. J Exp Med. 1956;104:411-8.
9. Hentges DJ, Stein AJ, Casey SW, Que JU. Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infect Immun. 1985;47:118-22.
10. Kennedy MJ, Volz PA. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun. 1985;49:654-63.
11. Que JU, Casey SW, Hentges DJ. Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun. 1986;53:116-23.
12. Freter R. Gnotobiotic and germfree animal systems. In: Poindexter JS, Leadbetter ER. editors. Bacteria in Nature, Vol. 2. New York: Plenum; 1986. p. 205-27.
13. Hirayama K. Ex-germfree mice harboring intestinal microbiota derived from other animal species as an experimental model for ecology and metabolism of intestinal bacteria. Exp Anim. 1999;48:219-27.
14. Hentges DJ, Marsh WW, Petschow BW, Thai WR, Carter MK. Influence of infant diets on the ecology of the intestinal tract of human flora-associated mice. J Pediatr Gastroenterol Nutr. 1992;14:146-52.
15. Narushima S, Itoh K, Mitsuoka T, Nakayama H, Itoh T, Hioki K, et al. Effect of mouse intestinal bacteria on incidence of colorectal tumors induced by 1,2-dimethylhydrazine injection in gnotobiotic transgenic mice harboring human prototype c-Ha-ras genes. Exp Anim. 1998;47:111-7.
16. Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. Die Faekalflora bei Menschen. IV. Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisherigen üblichen Verfahren zur Darmflora analyse. Zentralbl Bakt Hyg I Abt Orig. 1976;A234:219-33.
17. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol. 1989;55:1100-5.
18. Mitsuoka T. Vergleichende Untersuchungen über die Bifidobakterien aus dem Verdauungstrakt von Menschen und Tieren (Zugleich die Beschreibung von B. thermophilum nov. spec. und B. pseudolongum nov. spec.). Zentralbl Bakt Parasit Infekt Hyg I Abt Orig. 1969;210:52-64.
19. Hoogkamp-korstanje JAA, Lindner JGEM, Marcelis JH, den Daas-Slagt H, de Vos NM. Composition and ecology of the human intestinal flora. Antonie van Leeuwenhoek. 1979; 45:35-40.
20. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol. 1984;28:975-86.
21. Miyamoto Y, Watanabe K, Tanaka R, Itoh K. Distribution analysis of six predominant Bacteroides species in normal human feces using 16S rDNA-targeted species-specific primers. Microb Ecol Health Dis. 2002;14:133-6.
22. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol. 1999;65:4506-12.
23. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001; 30:43-7.
24. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108:144-5.
25. Hentges DJ. The protective function of the indigenous intestinal flora. Pediatr Infect Dis. 1986;5:S17-20.
26. Savage DC. Factors influencing biocontrol of bacterial pathogens in the intestine. Food Tech. 1987;41:82-7.
27. Mitsuoka T, Sega T, Yamamoto S. Eine verbesserte Methodik der qualitativen und quantitativen Analyse der Darmflora von Menschen und Tieren. Zentralbl Bakt Parasit Infekt Hyg I Orig. 1965;195:455-69.